PURETECH HEALTH PLC
Get an alert when PURETECH HEALTH PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-06-30 (in 1mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-22 (this month)
Last made up 2025-05-08
Watchouts
None on the register
Cash
£208M
+46.9% highest in 3 filed years
Net assets
£302M
-11% vs 2023
Employees
80
-16.7% lowest in 3 filed years
Profit before tax
£18M
+135.7% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · latest reflected 2024-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Turnover | £11,577,465 | £2,468,495 | £3,578,947 | |
| Operating profit | -£146,632,320 | -£108,375,834 | -£100,885,841 | |
| Profit before tax | -£41,303,929 | -£49,390,660 | £17,623,425 | |
| Net profit | -£27,475,908 | -£26,762,787 | £20,594,514 | |
| Cash | £111,094,144 | £141,646,405 | £208,036,323 | |
| Total assets less current liabilities | — | £476,355,078 | £416,046,701 | |
| Net assets | — | £339,682,728 | £302,396,590 | |
| Equity | — | £339,682,728 | £302,396,590 | |
| Average employees | 144 | 96 | 80 | |
| Wages | £30,948,851 | £27,489,993 | £21,521,127 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Operating margin | -1266.5% | -4390.4% | -2818.9% | |
| Net margin | -237.3% | -1084.2% | 575.4% | |
| Return on capital employed | — | -22.8% | -24.2% | |
| Gearing (liabilities / total assets) | — | 34.0% | 32.3% | |
| Current ratio | — | 6.76x | 9.33x | |
| Interest cover | -1.38x | -24.07x | -8.42x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors confirm that they have made a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. This assessment was made by considering our strong financial position, current strategy, and management of principal risks.”
Group structure
- PURETECH HEALTH PLC · parent
- Gallop Oncology, Inc. 100%
- Entr?ga, Inc. 7.3%
- LYT-100 PureTech LLC 100%
- LYT-200 PureTech LLC 100%
- PureTech Management, Inc. 100%
- PureTech Health LLC 100%
- Seaport Therapeutics, Inc. 42.1%
- Vedanta Biosciences, Inc. 46.9%
- Vor Biopharma, Inc. 2.1%
Significant events
- “In 2024, PureTech returned $100 million to shareholders through a Tender Offer.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SHERWOOD, Charles | Secretary | 2024-04-23 | — | — |
| BARBER-LUI, Sharon | Director | 2022-03-24 | Jun 1973 | American |
| HOLCOMB, Michele Ann Mc Mahon | Director | 2024-09-23 | Apr 1968 | American |
| LAMATTINA, John Lawrence, Dr. | Director | 2015-06-05 | Jan 1950 | American |
| LANGER, Robert Samuel, Dr | Director | 2015-06-05 | Aug 1948 | American |
| LYNE, Robert William Henry | Director | 2025-12-18 | Sep 1983 | British |
| MAZUMDAR-SHAW, Kiran | Director | 2020-09-30 | Mar 1953 | Indian |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHOWRIRA, Bharatt | Secretary | 2021-04-14 | 2024-04-23 |
| MUNIZ, Stephen | Secretary | 2015-05-08 | 2021-04-14 |
| CHOWRIRA, Bharatt | Director | 2021-02-01 | 2025-07-16 |
| ITO, Joichi | Director | 2015-06-05 | 2019-09-07 |
| KUCHERLAPATI, Raju, Dr | Director | 2015-06-05 | 2025-07-08 |
| MUNIZ, Stephen | Director | 2015-05-08 | 2021-05-17 |
| SCARDINO, Marjorie Morris, Dame | Director | 2015-06-05 | 2022-12-31 |
| SHAPIRO, Bennett Michael, Dr. | Director | 2015-06-05 | 2020-06-11 |
| VIEHBACHER, Christopher | Director | 2015-06-05 | 2023-06-13 |
| ZOHAR, Daphne | Director | 2015-05-08 | 2024-04-08 |
| INTERTRUST TRUSTEES (UK) LIMITED | Corporate Director | 2015-05-08 | 2015-05-08 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 218 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-08 | CH01 | officers | Change person director company with change date | |
| 2026-05-08 | CH01 | officers | Change person director company with change date | |
| 2026-05-07 | CH01 | officers | Change person director company with change date | |
| 2026-02-02 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-02 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-19 | AA | accounts | Accounts with accounts type group | |
| 2025-05-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-30 | SH06 | capital | Capital cancellation shares | |
| 2024-10-30 | SH03 | capital | Capital return purchase own shares | |
| 2024-10-30 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2024-10-30 | SH04 | capital | Capital sale or transfer treasury shares with date currency capital figure | |
| 2024-09-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-13 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-09-13 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-09-13 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-09-13 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-09-13 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-09-13 | SH03 | capital | Capital return purchase own shares treasury capital date | |
| 2024-05-17 | AA | accounts | Accounts with accounts type interim |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 10
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+45%
£2,468,495 £3,578,947
-
Cash
+46.9%
£141,646,405 £208,036,323
highest in 3 filed years
-
Net assets
-11%
£339,682,728 £302,396,590
-
Employees
-16.7%
96 80
lowest in 3 filed years
-
Operating profit
+6.9%
-£108,375,834 -£100,885,841
highest in 3 filed years
-
Profit before tax
+135.7%
-£49,390,660 £17,623,425
highest in 3 filed years
-
Wages
-21.7%
£27,489,993 £21,521,127
lowest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers